Clinical Trial Update: hUC-MSC-sEV-001 Nasal Drops for Neurodegenerative Diseases [Phase 1]

View source ↗

Summary

Phase 1 trial update for hUC-MSC-sEV-001 nasal drops across several neurodegenerative diseases; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Amyotrophic Lateral Sclerosis
• Frontotemporal Dementia
• Lewy Body Dementia
• Multiple System Atrophy
• Parkinson Disease

Drugs mentioned

• hUC-MSC-sEV-001 Nasal Drops (human umbilical cord mesenchymal stem cell-derived small extracellular vesicles nasal drops)

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: Alzheimer Disease, Parkinson Disease | Phase 1 | Status: NOT_YET_RECRUITING